Original Source(s)
Related Content
AI Scribes: Efficiency for Whom?
Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.
January 27, 2026
-
3 min
GLP-1 Drugs Linked to GI Effects, Uncertain Signals
Umbrella review evaluates over 1,700 trials to assess noncardiometabolic outcomes beyond weight and glycemic effects.
April 16, 2026
-
3 min